1
|
Pizzato M, Santucci C, Parazzini F, Negri E, La Vecchia C. Cancer mortality patterns in selected Northern and Southern African countries. Eur J Cancer Prev 2024; 33:192-199. [PMID: 37997906 DOI: 10.1097/cej.0000000000000852] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2023]
Abstract
BACKGROUND Non-communicable diseases have been rapidly increasing in African countries. We provided updated cancer death patterns in selected African countries over the last two decades. METHODS We extracted official death certifications and population data from the WHO and the United Nations Population Division databases. We computed country- and sex-specific age-standardized mortality rates per 100 000 person-years for all cancers combined and ten major cancer sites for the periods 2005-2007 and 2015-2017. RESULTS Lung cancer ranked first for male cancer mortality in all selected countries in the last available period (with the highest rates in Réunion 24/100 000), except for South Africa where prostate cancer was the leading cause of death (23/100 000). Prostate cancer ranked second in Morocco and Tunisia and third in Mauritius and Réunion. Among Egyptian men, leukemia ranked second (with a stable rate of 4.2/100 000) and bladder cancer third (3.5/100 000). Among women, the leading cancer-related cause of death was breast cancer in all selected countries (with the highest rates in Mauritius 19.6/100 000 in 2015-2017), except for South Africa where uterus cancer ranked first (17/100 000). In the second rank there were colorectal cancer in Tunisia (2/100 000), Réunion (9/100 000) and Mauritius (8/100 000), and leukemia in Egypt (3.2/100 000). Colorectal and pancreas cancer mortality rates increased, while stomach cancer mortality rates declined. CONCLUSION Certified cancer mortality rates are low on a global scale. However, mortality rates from selected screening detectable cancers, as well as from infection-related cancers, are comparatively high, calling for improvements in prevention strategies.
Collapse
Affiliation(s)
- Margherita Pizzato
- Department of Clinical Sciences and Community Health, University of Milan, Milan
| | - Claudia Santucci
- Department of Clinical Sciences and Community Health, University of Milan, Milan
| | - Fabio Parazzini
- Department of Clinical Sciences and Community Health, University of Milan, Milan
| | - Eva Negri
- Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy
| | - Carlo La Vecchia
- Department of Clinical Sciences and Community Health, University of Milan, Milan
| |
Collapse
|
2
|
Dassen RRE, Pelders S, de Munck L, Jager A, Hooning MJ, van Dam JH, Heemskerk-Gerritsen BAM. The effect of attendance in the Dutch breast cancer screening program on breast tumor characteristics among migrant women. Breast 2023; 69:290-298. [PMID: 36940631 PMCID: PMC10034141 DOI: 10.1016/j.breast.2023.03.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/24/2022] [Revised: 02/10/2023] [Accepted: 03/14/2023] [Indexed: 03/17/2023] Open
Abstract
BACKGROUND In general, migrant women have a lower breast cancer (BC) incidence rate and higher BC mortality than autochthonous women. Further, migrant women show lower participation in the national BC screening program. To further investigate those aspects, we aimed to determine differences in incidence and tumor characteristics between autochthonous and migrant BC patients in Rotterdam, the Netherlands. METHODS We selected women diagnosed with BC in Rotterdam during 2012-2015 from the Netherlands Cancer Registry. Incidence rates were calculated by migrant status (i.e., women with or without migration background). Multivariable analyses revealed adjusted odds ratios (OR) and 95% confidence intervals (CI) on the association between migration status and patient and tumor characteristics, additionally stratified by screening attendance (yes/no). RESULTS In total 1372 autochthonous and 450 migrant BC patients were included for analysis. BC incidence was lower among migrants than among autochthonous women. Overall, migrant women were younger at BC diagnosis (53 vs. 64 years, p < 0.001), and had higher risks of positive lymph nodes (OR 1.76, 95% CI 1.33-2.33) and high grade tumors (OR 1.35, 95% CI 1.04-1.75). Especially non-screened migrant women had higher risk of positive nodes (OR 2.73, 95% CI 1.43-5.21). Among the subgroup of screened women, we observed no significant differences between migrant and autochthonous patients. CONCLUSION Migrant women have lower BC incidence than autochthonous women, but diagnosis was more often at younger age and with unfavorable tumor characteristics. Attending the screening program strongly reduces the latter. Therefore, promotion of participation in the screening program is recommended.
Collapse
Affiliation(s)
- R R E Dassen
- Erasmus MC Cancer Institute, Medical Oncology, Rotterdam, Netherlands
| | - S Pelders
- Erasmus MC Cancer Institute, Medical Oncology, Rotterdam, Netherlands
| | - L de Munck
- Netherlands Comprehensive Cancer Organization, Research and Development, Utrecht, Netherlands
| | - A Jager
- Erasmus MC Cancer Institute, Medical Oncology, Rotterdam, Netherlands
| | - M J Hooning
- Erasmus MC Cancer Institute, Medical Oncology, Rotterdam, Netherlands
| | - J H van Dam
- Erasmus MC Cancer Institute, Oncological Surgery, Rotterdam, Netherlands
| | | |
Collapse
|
3
|
Incidence Trends of Cancer in Morocco: The Tale of the Oncological Center of Marrakech (Morocco) over 8 Years. J Cancer Epidemiol 2022; 2022:3307194. [PMID: 35265131 PMCID: PMC8901288 DOI: 10.1155/2022/3307194] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/07/2021] [Revised: 02/12/2022] [Accepted: 02/16/2022] [Indexed: 11/29/2022] Open
Abstract
Background Determining cancer incidence and mortality is a key factor in the implementation of health policies and cancer prevention strategies. This report aims to describe the trends of cancer incidence in a single referral oncology department from the Marrakech region (Morocco). Material and Methods. All new cancer cases of age ≥ 15 years registered at the Medical Oncology department of Mohammed VI University Hospital of Marrakesh between January 1, 2012, and December 31, 2019, were included. Central nervous system (CNS) cancers, tumors of hematopoietic and lymphoid tissues, and thyroid cancers for which chemotherapy was not indicated or was managed in other cancer-specialized departments were excluded from the analysis. Manual data collection from printed archived medical records of the study population was performed. Descriptive statistics were analyzed using R software and Joinpoint Regression Program. Results A total of 15648 new cancer cases were analyzed. Missing data (n = 1822) accounted for 11.64%, and 4.1% (n = 652) were excluded. The final statistical analysis and registration included 13174 cases. The median age at diagnosis is 54 years for females and 61 years for males. Female patients outnumbered males with a ratio of 1.58 among all age groups except those aged ≥75 y. The age-standardized incidence rate (ASIR) for all sites was 68,0 per 100.000 person-years, which has increased with an annual percent change (APC) of 10.61%. The five most common malignancies among males are lung, stomach, prostate, colic, and rectal cancers. Among females, the five most frequent cancers are breast, cervix, ovary, colon, and stomach. Conclusion The higher incidence observed in our results translates into a growing burden on the center and is expected to impact our ability to deliver cancer care. Epidemiological studies to identify risk factors and effective efforts are needed to further invest in cancer control and prevention plans.
Collapse
|
4
|
Khalis M, Diaby M, Toure AB, Charaka H, Abousselham L, Belakhel L, Bendahhou K, Al Hassani W, Soliman AS, Nejjari C. The Past, Present, and Future of Professional Cancer Education in Morocco. JOURNAL OF CANCER EDUCATION : THE OFFICIAL JOURNAL OF THE AMERICAN ASSOCIATION FOR CANCER EDUCATION 2021; 36:95-100. [PMID: 34046820 DOI: 10.1007/s13187-021-02039-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Accepted: 05/24/2021] [Indexed: 06/12/2023]
Abstract
Cancer is the second leading cause of death in Morocco after cardiovascular diseases. Changes associated with societal and economic development, longevity of the population, and lifestyle changes contribute to increasing the burden of cancer in the Morocco. Despite the advances and achievements in cancer care in Morocco, more efforts are needed to better treat, control, and prevent cancer in Morocco. This manuscript illustrates the professional cancer education activities in Morocco over the past 10 years. The manuscript also illustrates the current cancer education and the needed future directions in the field in this middle-income country that is undergoing significant epidemiologic and lifestyle transitions and projections for increasing cancer incidence and mortality in the next few decades.
Collapse
Affiliation(s)
- Mohamed Khalis
- International School of Public Health, Mohammed VI University of Health Sciences, Boulevard Mohammed Taïeb Naciri, Commune Hay Hassani Casablanca, 82403, Casablanca, Morocco.
| | - Maladho Diaby
- International School of Public Health, Mohammed VI University of Health Sciences, Boulevard Mohammed Taïeb Naciri, Commune Hay Hassani Casablanca, 82403, Casablanca, Morocco
| | - Aly Badara Toure
- International School of Public Health, Mohammed VI University of Health Sciences, Boulevard Mohammed Taïeb Naciri, Commune Hay Hassani Casablanca, 82403, Casablanca, Morocco
| | - Hafida Charaka
- Department of Research and Development, Hassan II University Hospital of Fez, Fez, Morocco
| | - Loubna Abousselham
- Epidemiology and Disease Control Department, Ministry of Health of Morocco, Rabat, Morocco
| | - Latifa Belakhel
- Epidemiology and Disease Control Department, Ministry of Health of Morocco, Rabat, Morocco
| | | | - Wafaa Al Hassani
- Faculty of Nursing and Allied Health Sciences, Mohammed VI University of Health Sciences, Casablanca, Morocco
| | - Amr S Soliman
- Department of Community Health and Social Medicine, School of Medicine, City University of New York, New York, NY, USA
| | - Chakib Nejjari
- International School of Public Health, Mohammed VI University of Health Sciences, Boulevard Mohammed Taïeb Naciri, Commune Hay Hassani Casablanca, 82403, Casablanca, Morocco
| |
Collapse
|
5
|
Acheampong E, Adu EA, Obirikorang C, Amoah G, Afriyie OO, Yorke J, Anto EO, Gyamfi MA, Acheampong EN, Gyasi-Sarpong CK, Yeboah FA. Association of genetic variants with prostate cancer in Africa: a concise review. EGYPTIAN JOURNAL OF MEDICAL HUMAN GENETICS 2021. [DOI: 10.1186/s43042-021-00157-w] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022] Open
Abstract
Abstract
Background
Prostate cancer (PCa) has one of the highest heritability of all major cancers, where the genetic contribution has been documented, and knowledge about the molecular genetics of the disease is increasing. However, the extent and aspects to which genetic variants explain PCa heritability in Africa are limited.
Main body
In this review, we summarize studies that highlight how identified genetic variants explain differences in PCa incidence and presentation across ethnic groups. We also present the knowledge gaps in PCa genetics in Africa and why Africa represents an untapped potential ground for genetic studies on PCa. A significant number of genome-wide association studies, linkage, and fine-mapping analyses have been conducted globally, and that explains 30–33% of PCa heritability. The African ancestry has a significant mention in PCa incidence and presentation. To date, the candidate gene approach has replicated 23 polymorphisms including dinucleotide and trinucleotide repeats in 16 genes. CYP17-rs743572, CYP3A4-rs2740574, CYP3A5-rs776746, CYP3A43-rs501275, and haplotype blocks, containing these variants, are significantly associated with PCa among some population groups but not others. With the few existing studies, the extent of genetic diversity in Africa suggests that genetic associations of PCa to African ancestry go beyond nucleotide sequence polymorphisms, to a level of environmental adaptation, which may interpret genetic risk profiles. Also, the shreds of evidence suggest that evolutionary history contributes to the high rates of PCa relative to African ancestry, and genetic associations do not always replicate across populations.
Conclusion
The genetic architecture of PCa in Africa provides important contributions to the global understanding of PCa specifically the African-ancestry hypothesis. There is a need for more prostate cancer consortiums to justify the heritable certainties of PCa among Africans, and emphasis should be placed on the genetic epidemiological model of PCa in Africa.
Collapse
|
6
|
Saberian M, Mehrabani K, Shahraki HR. Clustering time trends of breast cancer incidence in Africa: a 27-year longitudinal study in 53 countries. Afr Health Sci 2021; 21:47-53. [PMID: 34394280 PMCID: PMC8356619 DOI: 10.4314/ahs.v21i1.8] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
Abstract
Background Breast cancer is the most common, frequently diagnosed cancer with the highest incidence among female worldwide. Although the incidence is decreasing in developed countries, it is on increase in most of the African countries. Objective This study aimed to identify different time trends of breast cancer incidence among African countries using latent mixture approach. Methods The information includes newly diagnosed breast cancer patients per 100,000 women for 53 African countries in a period of 1990–2016. Latent mixture modeling was performed in Mplus 7.4 software. Results The overall trend of breast cancer in Africa was increasing. Latent mixture model with 5 clusters was estimated as the best using fit indices and linear growth trajectories were specified for each cluster. Nigeria was the only country which belongs to a cluster with negative slope indicating a slow decrease in the breast cancer incidence; also, Seychelles was the only country that showed a sharp increase over time. 31 countries belonged to a cluster with a slope of 0.08, indicating that the incidence of breast cancer is almost constant over time. Cluster 3 including Algeria, Angola, Botswana, Central African Republic, Cote d'lvoire, Equatorial Guinea, Lesotho, Libya, Namibia, Somalia, Sudan, Swaziland, Uganda and Zimbabwe and cluster 2 including Gabon, Mauritius, Morocco, South Africa, Tunisia and Congo showed a slow and moderate increase in the incidence of breast cancer, respectively. Conclusion Providing health education programs is essential in African countries with rising trend of breast cancer during the last decades.
Collapse
Affiliation(s)
- Mehran Saberian
- Student Research Committee, Shahrekord University of Medical Sciences, Shahrekord, Iran Address: Rahmatieh educational complex, Shahrekord University of Medical Sciences, Shahrekord, Iran.
| | - Kamran Mehrabani
- Department of Biostatistics, Faculty of medicine, Shiraz University of medical sciences, Shiraz, Iran Address: Shiraz University of Medical Sciences, Zand Avenue, Shiraz, Iran.
| | - Hadi Raeisi Shahraki
- Department of Epidemiology and Biostatistics, Faculty of Health, Shahrekord University of Medical Sciences, Shahrekord, Iran
| |
Collapse
|
7
|
Jabi R, Sergi B, Soufi M, El Arabi S, Miry A, El Harroudi T, Bouziane M. Acute hemoperitoneum after ruptured hepatocellular carcinoma: First Moroccan SCARE-compliant case report and literature review. Int J Surg Case Rep 2020; 66:390-393. [PMID: 31962261 PMCID: PMC6971371 DOI: 10.1016/j.ijscr.2019.12.038] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/21/2019] [Revised: 12/10/2019] [Accepted: 12/22/2019] [Indexed: 02/07/2023] Open
Abstract
Acute hemoperitoneum after a spontaneously ruptured hepatocellular carcinoma (HCC) is a rare complication. In cases with stable conditions, imaging guided by computed tomography (CT) enables arterial embolisation. Surgery is a choice after failure of embolisation or in case of severe hemodynamic instability. The prognostic outcomes of ruptured HCC depend mostly on the underlying liver function. Successful management by one-stage surgery allowed radical treatment of this rare entity.
Introduction Acute hemoperitoneum with a spontaneously ruptured hepatocellular carcinoma (HCC) is a rare type of internal bleeding that requires a multidisciplinary management approach. Presentation of case In this case report, we describe a fortuitously ruptured peripheral and discovered HCC in an 81-years-old woman treated effectively using hepatectomy. Discussion The use of the computed tomography (CT) angiography to diagnose the stability of the patient’s condition allows both arterial embolization in case of active bleeding and the evaluation of the underlying hepatopathy. The place of surgery is particularly upon after both the failure of arterial embolization and while facing a severe hemodynamic instability. The surgical strategy varies between perihepatic tamponnade and a surgical resection in one or more stages. The prognosis of a ruptured HCC depends mainly on the underlying liver’s function. Conclusion Multidisciplinary management of spontaneously ruptured HCC results in the same survival outcome as non-ruptured HCC at the same stage of hepatopathy.
Collapse
Affiliation(s)
- Rachid Jabi
- Department of General Surgery, Mohammed VI University Hospital, Faculty of Medicine and Pharmacy, Oujda, Morocco.
| | - Badr Sergi
- Department of General Surgery, Mohammed VI University Hospital, Faculty of Medicine and Pharmacy, Oujda, Morocco
| | - Mehdi Soufi
- Department of General Surgery, Ibn Zohr University, Faculty of Medicine and Pharmacy, Agadir, Morocco
| | - Soumia El Arabi
- Department of Radiology and Imaging, Mohammed VI University Hospital, Faculty of Medicine and Pharmacy, Oujda, Morocco
| | - Achraf Miry
- Department of Pathology, Mohammed VI University Hospital, Faculty of Medicine and Pharmacy, Oujda, Morocco
| | - Tijani El Harroudi
- Department of General Surgery, Mohammed VI University Hospital, Faculty of Medicine and Pharmacy, Oujda, Morocco
| | - Mohamed Bouziane
- Department of General Surgery, Mohammed VI University Hospital, Faculty of Medicine and Pharmacy, Oujda, Morocco
| |
Collapse
|
8
|
Belmokhtar KY, Tajir M, Boulouiz R, Bennani A, Brahmi SA, Alloubi I, Kouismi H, Kamaoui I, Skiker I, Afqir S, Abda N, Bellaoui M, Mezouar L. [Lung cancer in Eastern Morocco: where do we stand?]. Pan Afr Med J 2019; 34:177. [PMID: 32153717 PMCID: PMC7046119 DOI: 10.11604/pamj.2019.34.177.19934] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/31/2019] [Accepted: 10/29/2019] [Indexed: 01/22/2023] Open
Abstract
Introduction Lung cancer is the most common cancer in men living Eastern Morocco. We here present the first report on the clinical, pathological and therapeutic features of lung cancer in Eastern Morocco. Methods We conducted a retrospective study of 738 patients diagnosed with lung cancer at the Hassan II, Oncology Center between October 2005 and December 2014. Results Among the cases studied, 671 patients were men and 67 women; 95.01% of men and 1.54% of women were smokers. The average age of patients was 59.1 ± 11.9 years. Most patients (97%) were diagnosed at advanced stage disease. Only 4 out of 227 patients with advanced adenocarcinoma underwent molecular test. In addition, no patient in our series received targeted therapy. In this series, 20.46% of patients had less than 50 years. Compared to patients aged 50 years and older, cannabis consumption was higher (p<0.001) in patients less than 50 years and as well as a higher rate of adenocarcinoma (p<0.01). By contrast, in these patients, tobacco consumption was lower (p<0.001) as well as the rate of squamous cell carcinoma (p<0.01) and small cell cancer (p<0.05). Conclusion Unlike Western countries, in Eastern Morocco lung cancer is diagnosed late, affects younger people and access to molecular tests is still very limited. These results justify the need to implement effective programs against lung cancer as well as to facilitate access to molecular tests and new therapeutic tools in Eastern Morocco.
Collapse
Affiliation(s)
- Karam Yahya Belmokhtar
- Genetics Unit, Faculty of Medicine and Pharmacy of Oujda, University Mohammed Premier, Oujda, Morocco
| | - Mariam Tajir
- Genetics Unit, Faculty of Medicine and Pharmacy of Oujda, University Mohammed Premier, Oujda, Morocco
| | - Redouane Boulouiz
- Genetics Unit, Faculty of Medicine and Pharmacy of Oujda, University Mohammed Premier, Oujda, Morocco
| | - Amal Bennani
- Genetics Unit, Faculty of Medicine and Pharmacy of Oujda, University Mohammed Premier, Oujda, Morocco
| | - Sami Aziz Brahmi
- Faculty of Medicine and Pharmacy of Oujda, University Mohammed Premier, Mohammed VI University Hospital, Oujda, Morocco.,Hassan II Oncology Center, Oujda, Morocco
| | - Ihsan Alloubi
- Faculty of Medicine and Pharmacy of Oujda, University Mohammed Premier, Mohammed VI University Hospital, Oujda, Morocco
| | - Hatim Kouismi
- Faculty of Medicine and Pharmacy of Oujda, University Mohammed Premier, Mohammed VI University Hospital, Oujda, Morocco
| | - Imane Kamaoui
- Faculty of Medicine and Pharmacy of Oujda, University Mohammed Premier, Mohammed VI University Hospital, Oujda, Morocco
| | - Imane Skiker
- Faculty of Medicine and Pharmacy of Oujda, University Mohammed Premier, Mohammed VI University Hospital, Oujda, Morocco
| | - Said Afqir
- Faculty of Medicine and Pharmacy of Oujda, University Mohammed Premier, Mohammed VI University Hospital, Oujda, Morocco.,Hassan II Oncology Center, Oujda, Morocco
| | - Naima Abda
- Faculty of Medicine and Pharmacy of Oujda, University Mohammed Premier, Mohammed VI University Hospital, Oujda, Morocco
| | - Mohammed Bellaoui
- Genetics Unit, Faculty of Medicine and Pharmacy of Oujda, University Mohammed Premier, Oujda, Morocco
| | - Loubna Mezouar
- Faculty of Medicine and Pharmacy of Oujda, University Mohammed Premier, Mohammed VI University Hospital, Oujda, Morocco.,Hassan II Oncology Center, Oujda, Morocco
| |
Collapse
|
9
|
Saidi O, Hajjem S, Zoghlami N, Aounallah-Skhiri H, Ben Mansour N, Hsairi M, Romdhane HB, Critchley JA, Mallouche D, O'Flaherty M, Fakhfakh R. Premature mortality attributable to smoking among Tunisian men in 2009. Tob Induc Dis 2019; 17:77. [PMID: 31768169 PMCID: PMC6843183 DOI: 10.18332/tid/112666] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/31/2018] [Revised: 05/12/2019] [Accepted: 09/28/2019] [Indexed: 11/24/2022] Open
Abstract
INTRODUCTION Tobacco smoking is a significant public health threat in the world, a risk factor for many diseases, and has been increasing in prevalence in many developing countries. In this study, we aimed to estimate the burden of premature deaths attributable to smoking among Tunisian men aged 35–69 years in 2009. METHODS The number of deaths attributable to smoking was estimated using the population attributable risk fraction method. Smoking prevalence was obtained from a nationally representative survey. Causes of death were obtained from the registry of the National Public Health Institute. Relative risks were taken from the American Cancer Society Prevention Study (CPS-II). RESULTS Total estimated premature deaths attributable to smoking among men in Tunisia were 2601 (95% CI: 2268–2877), accounting for 25% (95% CI: 23.3–26.6) of total male adult mortality. Cancer, cardiovascular and respiratory diseases were the major causes of premature deaths attributable to smoking with 1272 (95% CI: 1188–1329), 966 (95% CI: 779–1133) and 364 (300–415) deaths, respectively. CONCLUSIONS Tobacco smoking is highly relevant and is related to substantial premature mortality in Tunisia, around double that estimated for the region as a whole. This also has not decreased over the past 20 years. Urgent actions are needed to reduce this pandemic.
Collapse
Affiliation(s)
- Olfa Saidi
- National Institute of Public Health, Ministry of Health, Tunis, Tunisia.,Research Laboratory of Epidemiology and Prevention of Cardiovascular Diseases, Faculty of Medicine, University Tunis El Manar, Tunis, Tunisia
| | - Said Hajjem
- National Institute of Public Health, Ministry of Health, Tunis, Tunisia
| | - Nada Zoghlami
- National Institute of Public Health, Ministry of Health, Tunis, Tunisia.,Research Laboratory of Epidemiology and Prevention of Cardiovascular Diseases, Faculty of Medicine, University Tunis El Manar, Tunis, Tunisia
| | - Hajer Aounallah-Skhiri
- National Health Institute, Tunis, Tunisia.,Faculty of Medicine of Tunis, University of Tunis El-Manar, Tunis, Tunisia.,The SURVEN (Nutrition Surveillance and Epidemiology in Tunisia) Research Laboratory, National Institute of Nutrition and Food Technology, Tunis, Tunisia
| | - Nadia Ben Mansour
- National Institute of Public Health, Ministry of Health, Tunis, Tunisia.,Research Laboratory of Epidemiology and Prevention of Cardiovascular Diseases, Faculty of Medicine, University Tunis El Manar, Tunis, Tunisia
| | | | - Habiba Ben Romdhane
- Research Laboratory of Epidemiology and Prevention of Cardiovascular Diseases, Faculty of Medicine, University Tunis El Manar, Tunis, Tunisia
| | - Julia A Critchley
- Division of Population Health Sciences and Education, St George's, University of London, London, United Kingdom
| | - Dhafer Mallouche
- National Institute of Statistics and Data Analysis, Tunis, Tunisia
| | - Martin O'Flaherty
- Department of Public Health and Policy, University of Liverpool, Liverpool, United Kingdom
| | - Radhouane Fakhfakh
- National Institute of Public Health, Ministry of Health, Tunis, Tunisia.,Unit of Research in Tobacco Epidemiology and Control, Tunis, Tunisia
| |
Collapse
|
10
|
Belglaiaa E, Mougin C. [Cervical cancer: Current situation and management in Morocco]. Bull Cancer 2019; 106:1008-1022. [PMID: 31606139 DOI: 10.1016/j.bulcan.2019.08.020] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/09/2019] [Revised: 07/09/2019] [Accepted: 08/27/2019] [Indexed: 12/24/2022]
Abstract
With more than 3300 new cases and almost 2500 deaths each year, cervical cancer (CC) ranks second among female cancers in Moroccan women. The majority of cases occurs in women aged 50 and over. In absence of a national cancer registry, data published in Morocco are limited to the number of cases recorded in some oncology centers, so the incidence of this cancer is likely much higher than estimated. A Moroccan national program against CC based on the practice of visual inspection after application of acetic acid was set up in 2010, allowing both screening and possibly immediate treatment of (pre)cancerous lesions. However, this program has not been implemented in all regions of the country. The CC develops slowly and most often without any symptoms, and so it is diagnosed at an advanced stage of the disease. Virtually, all CC are associated with persistent infection of high risk human papillomavirus (HPV), particularly HPV16 and 18. For more than ten years, two prophylactic vaccines targeting these two HPV genotypes have been marketed. They have proved their excellent immunogenicity and efficacy and they are well tolerated. However, HPV vaccine is not yet recommended by health authorities in Morocco. In this literature review, we focused on the current situation of CC, the prevalence of HPV infection and the prevention strategies against CC in Morocco.
Collapse
Affiliation(s)
- Essaada Belglaiaa
- Institut supérieur des professions infirmières et techniques de santé, département des soins infirmiers, Laâyoune, Maroc; Université de Bourgogne Franche-Comté, EA 3181, LabExLipSTIC ANR-11-LABX-0021, 25000 Besançon, France
| | - Christiane Mougin
- Université de Bourgogne Franche-Comté, EA 3181, LabExLipSTIC ANR-11-LABX-0021, 25000 Besançon, France; CHU, centre national de référence des papillomavirus (CNRP), 25000 Besançon, France.
| |
Collapse
|
11
|
Kołacińska A, Herman K, Morawiec J, Paszek S, Zawlik I, Śliwczyński A. Improvement in outcomes of breast cancer patient treatment in Poland in the 21st century. Breast J 2019; 25:474-478. [PMID: 30982222 DOI: 10.1111/tbj.13245] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/03/2018] [Revised: 06/11/2018] [Accepted: 06/18/2018] [Indexed: 12/12/2022]
Abstract
Breast cancer accounts for 22%-25% of all female cancers diagnosed worldwide. The aim of study was to compare the 5-year relative survival rates for breast cancer patients treated in the years 2008-2010, 2000-2002, and 2005-2007, and to determine their relationships with the methods and costs of treatment. Data were collected from the National Cancer Registry and the Narodowy Fundusz Zdrowia (National Health Fund) data bases. An increase in the 5-year survival rate was observed. The results show the impact of some factors on the survival and treatment costs. It is necessary to create data bases being a platform for further comprehensive analyses.
Collapse
Affiliation(s)
- Agnieszka Kołacińska
- Department of Head and Neck Cancer Surgery, Medical University of Lodz, Lodz, Poland.,Breast Unit, Cancer Center, Copernicus Memorial Hospital, Lodz, Poland
| | | | - Jan Morawiec
- Department of General and Colorectal Surgery, Medical University of Lodz, Lodz, Poland
| | - Sylwia Paszek
- Laboratory of Molecular Biology, Centre for Innovative Research in Medical and Natural Sciences, Faculty of Medicine, University of Rzeszow, Rzeszow, Poland
| | - Izabela Zawlik
- Laboratory of Molecular Biology, Centre for Innovative Research in Medical and Natural Sciences, Faculty of Medicine, University of Rzeszow, Rzeszow, Poland.,Department of Genetics, Institution of Experimental and Clinical Medicine, Faculty of Medicine, University of Rzeszow, Rzeszow, Poland
| | | |
Collapse
|
12
|
Rates of Prevalent Colorectal Cancer Occurrence in Persons 75 Years of Age and Older: A Population-Based National Study. Dig Dis Sci 2018; 63:1929-1936. [PMID: 29675660 DOI: 10.1007/s10620-018-5073-9] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/25/2018] [Accepted: 04/12/2018] [Indexed: 12/13/2022]
Abstract
BACKGROUND/AIMS There is a lack of studies describing the epidemiology of colorectal cancer (CRC) in patients aged 75 years and older (elderly). Current guidelines recommend against routine screening colonoscopies in this population. We sought to describe the epidemiology of CRC in the elderly, utilizing a large, population-based database as this may impact screening guidelines in this population. METHODS Utilizing a commercial database (Explorys Inc, Cleveland, OH), we identified a cohort of patients with a first-ever diagnosis of CRC between 2012 and 2017 based on the Systematized Nomenclature of Medicine-Clinical Terms. We calculated the rate of first-ever CRC occurrence in the elderly, described age, race, and gender-based rates of new CRC diagnoses, and identified associated conditions for new CRC in the elderly. RESULTS The rate of first-ever CRC in the elderly (aged 75 and above) was 102.6/100,000 persons. The rate of new CRC was higher in males than females and in African Americans than Caucasians and Asians. There was a higher prevalence of right than left colon cancer. The rate of new CRC was higher in elderly with certain comorbidities. CONCLUSION The rate of new CRC diagnosis in the elderly was substantially greater compared to the overall population. Screening would be justified especially if a patient's life expectancy warrants it particularly if the patient has specific associated conditions that increase the risk for CRC.
Collapse
|